-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
April 01, 2012 - Duloxetine resulted in improved UI in 75-140 women per
1,000 treated, while 129 women per 1,000 treated … Oxybutynin resolved UI in 114 women per 1,000 treated
(95% CI, 64 to 163), while 63 women per 1,000 … treated
(95% CI, 12 to 127) discontinued oxybutynin because of
adverse effects. … treated
(95% CI, 47 to 120) experienced adverse effects. … treated (95% CI, 118 to 260) experienced adverse
effects.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
May 01, 2020 - When left untreated or
ineffectively treated, adolescents with substance use disorders are at risk of … The pervasive
negative consequences associated with untreated or ineffectively treated adolescent
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - expert comments were collected for this report indicated that patients
with severe persistent asthma treated … They also
reported that 79% of patients treated with BT and 64% of patients treated with sham achieved … Six percent more BT-treated patients were hospitalized during the
treatment period (up to 6 weeks after … annual meeting of the American Thoracic Society stated that patients
with severe refractory asthma treated … Patients treated with ivacaftor also demonstrated a significant
improvement in quality of life (p <
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
January 01, 2007 - influenced by retrospective cohort studies,
where medication discontinuation rates were higher in
ACEI-treated … adverse events, in which the NNT is on the order of
27—that is, 1 more withdrawal per 27 patients treated … Angioedema was reported only in patients treated with
ACEIs; however, because angioedema was rarely
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
April 01, 2013 - There was one additional death for every
59 treated patients when the control arm on-study
mortality … was 10 percent, and there was one additional
death for every 588 treated patients when the control … interval; RR = relative risk
5
Rates of thromboembolic events were consistently higher
in ESA-treated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - First, all patients presenting
with UA/NSTEMI are treated with an initial dose of
aspirin, followed … In patients treated for UA/NSTEMI after
hospitalization (postdischarge):
a. … patients and heparin-treated patients
(low SOE) … patients (4.1% and 11.2%) vs. heparin-treated (5.7% and 12.5%)
Major bleeding at 30 days SOE = High … >12 months) showed similar rates across treatment groups in both DES-treated and
BMS-treated populations
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - Radiographic
changes were not different for those treated with
leflunomide and those treated with sulfasalazine … Radiographic
outcomes, however, were statistically significantly
better in patients treated with biologic … Patients treated with initial combination
therapy of methotrexate, sulfasalazine, and tapered high-
dose … Investigators may find large
registries helpful in identifying the same kinds of
patients treated with … The group treated with biologics had poorer baseline
characteristics than the methotrexate group; once
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
August 01, 2016 - Health care utilization studies* report reduced medical costs
among patients treated with AUD medication … when compared
with patients treated without it.2 A meta-analysis of three health
care utilization
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
December 01, 2015 - Patients treated for 12 weeks had an SVR12 of 95%. … The SVR12 rate for patients treated with Harvoni with or without RBV for 12 weeks was
94% and 96%, … In patients treated with or without RBV for 24 weeks, 99% in both
groups achieved SVR12.24 … In patients treated for 12 weeks, 92% achieved SVR12; in patients treated for
24 weeks, 96% achieved … Ledipasvir and sofosbuvir for previously treated
HCV genotype 1 infection.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
January 01, 2015 - Key Questions
This systematic review examined whether specific
subgroups would benefit from being treated … presented for within-stratum results—such
as stratum-specific change in pain for those with MDD
(treated … vs. controls) and for those without MDD (treated
vs. controls)—we report within-stratum information … Study
authors noted similar improvements in PGI-I in treated
patients versus controls regardless of … patients with MDD relative to treated
adults without MDD.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
July 08, 2014 - There
are few studies that compare outcomes in depressed
untreated and depressed treated women. … Text at the beginning of the paragraph changed to: “Evidence on
harms to the child of a mother treated … It underscores the
fundamental need for better characterization of the
population being treated and … studied, e.g. whether women
are being treated with an antidepressant due to
depression, as well as … Were the treated mothers symptom-free, or
did they still have clinical depression?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
May 01, 2015 - Treatment Strategies
Ankyloglossia may be treated with surgical or nonsurgical
approaches. … The one poor-quality RCT comparing surgical methods
reported improved articulation in patients treated … One poor-quality RCT reported improved articulation
in patients treated with Z-frenuloplasty compared … Longer term followup of
both treated infants and controls is needed. … Larger studies
that assess both treated and untreated individuals could
provide useful data to minimize
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - Compared with placebo, study participants treated with acamprosate were more
likely to experience anxiety … In head-to-head studies,
patients treated with acamprosate had a slightly lower risk of headache and … vomiting than
those treated with naltrexone.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
May 01, 2012 - A requirement (for some indications) that
the patient be treated as part of a clinical
trial.
4. … Figure 2: Growth in number of beneficiaries treated with proton beam radiotherapy by facility, … However, from 2006 to 2009, the
number of beneficiaries treated increased from about 740 to almost 1,200 … Over this same period, the
number of beneficiaries treated
for conditions of possible benefit
(Group … However, many are being treated for tumors for which there is far less consensus about this therapy's
-
effectivehealthcare.ahrq.gov/products/autoimmune-disease/rapid-research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - Of 339 alcohol-treated
stool samples cultured on IDCd media and five other
selective agars, C. diff … with
fidaxomicin, 62
treated with
vancomycin
fidaxomicin (200 mg
twice daily) vs. … patients treated with fidaxomicin (-15.8% difference,
95% CI: -30.4% to -0.3%l P=0.045). … treated with
fidaxomicin (P=0.003). … In comparison with
vancomycin-treated patients, fidaxomicin-treated
patients had reduced acquisition
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Patients treated with azithromycin were reported to have a longer median
time to the first exacerbation … and less-frequent exacerbations than patients treated with
placebo. … Additionally, investigators noted concern about antibiotic-resistant bacteria in
patients treated with … Patients treated with ivacaftor also demonstrated a significant improvement in quality of
life (p<0.001 … time to first exacerbation was 266 days (95% confidence interval [CI], 227 to 313) among patients
treated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
November 01, 2017 - Question 3: For patients with confirmed or
suspected opioid overdose in out-of-hospital settings
treated … opioid
overdose who exhibit altered mental status, miosis, or
respiratory depression and who are treated … dosing strategies in EMS personnel
– For Key Questions 1 and 1a, also include studies
of patients treated … Question 3: For patients with confirmed or
suspected opioid overdose in out-of-hospital settings
treated … Assessment for deaths in
out-of-hospital heroin overdose patients treated with naloxone
who refuse
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
January 15, 2013 - dietary control (IDC) of Phe
on pre-attentive processing in
children with early and
continuously treated … Phe levels were
reduced by at least 30 percent in
up to half of treated participants
(32 to 50 percent … Pre-attentive processing in children
with early and continuously-treated PKU. … The neuropsychological
profile of early and continuously treated
phenylketonuria: orienting, vigilance … Phe levels were reduced
by at least 30 percent in up to half of treated
participants (32 to 50 percent
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
November 01, 2014 - immunocompetent
patients.1,5
Because HAP, VAP, and HCAP share similar microbial
sources, they are treated … guide dosing
of antibiotics have important implications, not only for the
individual patient being treated … for this review include adults who
have presumed or confirmed HAP, VAP, or HCAP and who
are being treated … HAP had to have begun in a
health care setting (e.g., skilled nursing facility) and be
treated in the … Clinical cure of
ventilator-associated pneumonia treated with piperacillin/
tazobactam administered